2023
A systematic review and meta-analysis of neuromodulation therapies for substance use disorders
Mehta D, Praecht A, Ward H, Sanches M, Sorkhou M, Tang V, Steele V, Hanlon C, George T. A systematic review and meta-analysis of neuromodulation therapies for substance use disorders. Neuropsychopharmacology 2023, 49: 649-680. PMID: 38086901, PMCID: PMC10876556, DOI: 10.1038/s41386-023-01776-0.Peer-Reviewed Original ResearchRepetitive transcranial magnetic stimulationTranscranial direct current stimulationSubstance use disordersDeep brain stimulationDorsolateral prefrontal cortexUse disordersEffects of rTMSTreatment of SUDsSubstance useLong-term outcomesLeft dorsolateral prefrontal cortexTranscranial magnetic stimulationSystematic literature searchDirect current stimulationEffect sizeSubstance use outcomesAddiction neurocircuitryUncontrolled studiesDBS studiesNeuromodulation therapiesMagnetic stimulationPsychosocial treatmentsBrain stimulationTreatment durationAdministration protocol
2019
67 Appraisal of Follow-up Protocols and Outcomes of High Risk Pancreatic Cancer Surveillance Programs: A Systematic Review and Meta-Analysis
Chhoda A, Mukherjee E, Wattamwar K, Kastrinos F, Farrell J. 67 Appraisal of Follow-up Protocols and Outcomes of High Risk Pancreatic Cancer Surveillance Programs: A Systematic Review and Meta-Analysis. The American Journal Of Gastroenterology 2019, 114: s40-s41. DOI: 10.14309/01.ajg.0000589800.17291.ef.Peer-Reviewed Original ResearchHigh-risk individualsCross-sectional imagingEndoscopic ultrasoundPancreatic cancerDiagnostic rateSectional imagingSystematic reviewPt-yrNew lesionsBaseline imagingAdvanced pathologyCumulative progression rateCancer Surveillance ProgramOptimal imaging modalityPre-existing abnormalitiesSignificant differencesOutcomes of interestRandom-effects modelFirst systematic reviewUncontrolled studiesProspective studySubgroup analysisSurveillance protocolHistologic diagnosisProgression rate
2015
Catehol‐o‐methyltransferase gene Val158met polymorphism as a potential predictor of response to computer‐assisted delivery of cognitive‐behavioral therapy among cocaine‐dependent individuals: Preliminary findings from a randomized controlled trial
Carroll KM, Herman A, DeVito EE, Frankforter TL, Potenza MN, Sofuoglu M. Catehol‐o‐methyltransferase gene Val158met polymorphism as a potential predictor of response to computer‐assisted delivery of cognitive‐behavioral therapy among cocaine‐dependent individuals: Preliminary findings from a randomized controlled trial. American Journal On Addictions 2015, 24: 443-451. PMID: 25930952, PMCID: PMC4516567, DOI: 10.1111/ajad.12238.Peer-Reviewed Original ResearchConceptsCognitive behavioral therapyComputerized cognitive behavioral therapyVal carriersStandard treatmentCocaine-dependent individualsCocaine useStandard methadone maintenance treatmentComputer-assisted deliveryMethadone maintenance treatmentMet/Met genotypeRate of participantsSignificant treatment conditionLess cocaine useCOMT Val108/158Met polymorphismPreliminary data pointUncontrolled studiesMaintenance treatmentContinuous abstinenceTreatment outcomesTreatment responseWeek trialMet genotypePotential biomarkersBehavioral therapyVal108/158Met polymorphism
2007
Treatments for Pathological Gambling and Other Impulse Control Disorders
Grant J, Potenza M. Treatments for Pathological Gambling and Other Impulse Control Disorders. 2007, 561-578. DOI: 10.1093/med:psych/9780195304145.003.0020.ChaptersImpulse control disordersPharmacological treatmentControl disordersTreatment studiesPathological gamblingPharmacological treatment studiesPharmacological therapyUncontrolled studiesLong-term benefitsDrug treatmentLong-term effectsOutcome studiesSmall studyPharmacological studiesPsychological treatmentDisordersTreatmentMixed resultsSpecific behavioralCBTPotential benefitsPlaceboShort termTherapySymptoms
2005
Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
Kowdley K, Brandhagen D, Gish R, Bass N, Weinstein J, Schilsky M, Fontana R, McCashland T, Cotler S, Bacon B, Keeffe E, Gordon F, Polissar N. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry. Gastroenterology 2005, 129: 494-503. PMID: 16083706, DOI: 10.1016/j.gastro.2005.05.004.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAnalysis of VarianceCause of DeathCohort StudiesConfidence IntervalsFemaleGenetic MarkersGenotypeHemochromatosisHistocompatibility Antigens Class IHumansIron OverloadLiver Function TestsLiver TransplantationMaleMiddle AgedMutationProbabilityPrognosisProportional Hazards ModelsRegistriesSensitivity and SpecificitySeverity of Illness IndexSurvival AnalysisConceptsHepatic iron overloadHepatic iron indexHepatic iron concentrationLiver transplantationIron overloadPosttransplantation survivalC282Y/H63D mutationsEnd-stage liver diseaseHFE gene testingHFE mutation statusLiver transplantation centerNon-HH patientsOrgan Sharing statusYear of transplantationWild-type patientsPostliver transplantationTransplant RegistryHazard ratioTransplantation centersUncontrolled studiesLiver diseasePoor outcomeUnited NetworkIron indicesEarly diagnosis
2000
Therapeutic Angiogenesis With Recombinant Fibroblast Growth Factor-2 Improves Stress and Rest Myocardial Perfusion Abnormalities in Patients With Severe Symptomatic Chronic Coronary Artery Disease
Udelson J, Dilsizian V, Laham R, Chronos N, Vansant J, Blais M, Galt J, Pike M, Yoshizawa C, Simons M. Therapeutic Angiogenesis With Recombinant Fibroblast Growth Factor-2 Improves Stress and Rest Myocardial Perfusion Abnormalities in Patients With Severe Symptomatic Chronic Coronary Artery Disease. Circulation 2000, 102: 1605-1610. PMID: 11015335, DOI: 10.1161/01.cir.102.14.1605.Peer-Reviewed Original ResearchConceptsAdvanced coronary diseaseCoronary diseaseRFGF-2Day 29Myocardial perfusionDay 180Day 57Chronic coronary artery diseaseTherapeutic angiogenesisRest perfusion scoreStress-induced ischemiaCoronary artery diseaseMyocardial perfusion abnormalitiesSingle photon emissionMechanical revascularizationNonstudy patientsArtery diseaseUncontrolled studiesDose groupPerfusion scanPerfusion abnormalitiesReversibility scoreIntravenous administrationPerfusion scoreFactor 2 (Nrf2) protein
1999
Peer Support Among Individuals With Severe Mental Illness: A Review of the Evidence
Davidson L, Chinman M, Kloos B, Weingarten R, Stayner D, Tebes J. Peer Support Among Individuals With Severe Mental Illness: A Review of the Evidence. Clinical Psychology Science And Practice 1999, 6: 165-187. DOI: 10.1093/clipsy.6.2.165.Peer-Reviewed Original ResearchSevere mental illnessConsumer-run servicesMutual support groupsMental illnessPsychiatric disabilitiesPeer supportSupport groupsQuality of lifeUncontrolled studiesRecovery of individualsRehabilitative settingsIllnessDisabilityPotential effectivenessPrimary formIndividualsProvidersGroupPopulationSymptoms
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply